April 20, 2020 -- Medable has launched a research collaboration with five other organizations to develop diagnostics and treatment for COVID-19.
The initiative is called the American COVID-19 Collaborative Enabling Seamless Science, or ACCESS, and in addition to Medable, it includes BioIntelliSense, Datavant, Parexel, PWNHealth, and the American Heart Association's Center for Health Technology and Innovation. ACCESS facilitates at-home research, clinical trial access, and population-based long-term outcome studies.
Via a mobile app, it connects researchers and clinical trial teams with homebound patients in the U.S., Medable said. Patients can contribute information about their COVID-19 experience, which can then be combined with their health records. Patients can also opt to participate in clinical studies.
ACCESS also provides screening, disease and immunity status testing, and general lab testing through PWNHealth, and it offers researchers access to anonymized health records, claims, and diagnostic data through Datavant, Medable said.